Harvard Management as of March 31, 2023
Portfolio Holdings for Harvard Management
Harvard Management holds 48 positions in its portfolio as reported in the March 2023 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Alphabet Cap Stk Cl A (GOOGL) | 26.3 | $250M | 2.4M | 103.73 | |
Meta Platforms Cl A (META) | 25.3 | $241M | 1.1M | 211.94 | |
Scientific Games (LNW) | 16.9 | $161M | 2.7M | 60.05 | |
Grab Holdings Class A Ord (GRAB) | 4.1 | $39M | 13M | 3.01 | |
Abcellera Biologics (ABCL) | 3.3 | $31M | 4.1M | 7.54 | |
NVIDIA Corporation (NVDA) | 1.9 | $18M | 66k | 277.77 | |
Purecycle Technologies (PCT) | 1.8 | $18M | 2.5M | 7.00 | |
ASML Holding N V N Y Registry Shs (ASML) | 1.4 | $14M | 20k | 680.71 | |
Advanced Micro Devices (AMD) | 1.2 | $11M | 112k | 98.01 | |
Applied Materials (AMAT) | 1.1 | $11M | 88k | 122.83 | |
Analog Devices (ADI) | 1.1 | $11M | 55k | 197.22 | |
Qorvo (QRVO) | 1.1 | $11M | 105k | 101.57 | |
10X Genomics Cl A Com (TXG) | 1.1 | $10M | 186k | 55.79 | |
Meli Kaszek Pioneer Corp Class A Ord | 1.1 | $10M | 1.0M | 10.20 | |
Lam Research Corporation | 1.1 | $10M | 19k | 530.12 | |
Recursion Pharmaceuticals In Cl A (RXRX) | 1.1 | $10M | 1.5M | 6.67 | |
Taiwan Semiconductor Mfg Sponsored Ads (TSM) | 1.0 | $10M | 107k | 93.02 | |
Relay Therapeutics (RLAY) | 0.9 | $8.9M | 541k | 16.47 | |
Pliant Therapeutics (PLRX) | 0.8 | $7.5M | 281k | 26.60 | |
Eqrx | 0.8 | $7.5M | 3.9M | 1.94 | |
Revolution Medicines (RVMD) | 0.7 | $6.8M | 316k | 21.66 | |
Intel Corporation (INTC) | 0.7 | $6.8M | 208k | 32.67 | |
Micron Technology (MU) | 0.7 | $6.5M | 108k | 60.34 | |
Rocket Lab Usa (RKLB) | 0.4 | $4.0M | 1.0M | 4.04 | |
Confluent Class A Com (CFLT) | 0.3 | $3.1M | 130k | 24.07 | |
Kinnate Biopharma | 0.3 | $3.1M | 498k | 6.25 | |
Vigil Neuroscience (VIGL) | 0.3 | $2.8M | 290k | 9.79 | |
Tango Therapeutics (TNGX) | 0.3 | $2.8M | 708k | 3.95 | |
Nurix Therapeutics (NRIX) | 0.3 | $2.8M | 315k | 8.88 | |
Pacific Biosciences of California (PACB) | 0.3 | $2.7M | 229k | 11.58 | |
Generation Bio (GBIO) | 0.2 | $2.2M | 510k | 4.30 | |
Purecycle Technologies *w Exp 03/17/202 (PCTTW) | 0.2 | $2.2M | 714k | 3.06 | |
Affirm Hldgs Com Cl A (AFRM) | 0.2 | $2.0M | 174k | 11.27 | |
Tenaya Therapeutics (TNYA) | 0.2 | $1.9M | 673k | 2.85 | |
Sana Biotechnology (SANA) | 0.2 | $1.5M | 469k | 3.27 | |
Nauticus Robotics | 0.2 | $1.5M | 500k | 2.98 | |
Xilio Therapeutics (XLO) | 0.1 | $1.3M | 416k | 3.18 | |
Dyne Therapeutics (DYN) | 0.1 | $1.2M | 107k | 11.52 | |
UI Path Cl A (PATH) | 0.1 | $1.2M | 69k | 17.56 | |
Fulcrum Therapeutics (FULC) | 0.1 | $1.2M | 411k | 2.85 | |
Decibel Therapeutics | 0.1 | $993k | 329k | 3.02 | |
Seres Therapeutics (MCRB) | 0.1 | $748k | 132k | 5.67 | |
Praxis Precision Medicines I | 0.1 | $630k | 779k | 0.81 | |
Disc Medicine (IRON) | 0.1 | $530k | 25k | 21.19 | |
Pardes Biosciences | 0.1 | $528k | 400k | 1.32 | |
Surrozen | 0.1 | $498k | 827k | 0.60 | |
Lo (LOCO) | 0.0 | $433k | 45k | 9.59 | |
Magenta Therapeutics | 0.0 | $264k | 333k | 0.79 |